It’s still a bull thesis, just subverted: Inhibikase Therapeutics Inc (IKT)
A share price of Inhibikase Therapeutics Inc [IKT] is currently trading at $1.89, up 2.16%. An important factor to consider is whether the stock is rising or falling in short-term value. The IKT shares have gain 14.55% over the last week, with a monthly amount drifted -6.90%, and not seem to be holding up well […]